Bajaj Finserv
|

Bajaj Finance Limited

|
Sign In
EMI Card
Notifications
Notifications
Cart
Prime
Partners
  • Fixed Deposit (IFA) Partner Fixed Deposit (IFA) Partner
  • Loan (DSA) Partner Loan (DSA) Partner
  • Debt Management Partner Debt Management Partner
  • EMI Network Partner EMI Network Partner
  • Become a Merchant Become a Merchant
  • Demat and mutual fund partner Demat and mutual fund partner
  • Partners Sign In Partners Sign In
Menu
  • Loans
    • All Loans
    • Personal Loan Apply Online Check Offer
      • Overview Flexi Personal Loan Features and Benefits Eligibility Calculator Fees and Charges How to Apply FAQs Manage your Loans Manage your Flexi Loans Contact Us
      • Loans for your Goals

        • Loan for Wedding
        • Loan for Higher Education
        • Loan for Home Renovation
        • Loan for Medical Emergency
    • Insta Personal Loan Check Offer Pre-approved Offer
      • Overview Features Eligibility Calculator Fees and Charges How to Apply Manage your Loans
      • Loans for your Goals

        • Loan for Wedding
        • Loan for Higher Education
        • Loan for Home Renovation
        • Loan for Medical Expenses
    • Business Loan Apply Online Check Offer

        Unsecured

      • MSME World Overview Features EMI Calculator Eligibility How to Apply Fees & Charges Manage your Loans Manage your Flexi Loans
      • Secured

      • Overview Features EMI Calculator Eligibility How to Apply Fees & Charges Manage your Loans Manage your Flexi Loans
      • Types of Business Loans

      • Business Loan for Chartered Accountants Loan Against Property for Chartered Accountant Personal Loan for Chartered Accountants
    • Gold Loan Apply Online

        New Loan

      • Overview Features EMI Calculator Eligibility How to Apply Manage your Gold Loan Interest Rate and Charges Gold Rate
      • Balance Transfer

      • Overview Features EMI Calculator Eligibility How to Apply Interest Rate and Charges
    • Loans for Doctors Apply Online Check Offer

        UNSECURED

      • Doctor World Overview Features Eligibility How to Apply Fees & Charges Manage your Loans Manage your Flexi Loans
      • SECURED

      • Overview EMI Calculator Features Eligibility How to Apply Fees and charges Manage your loan
      • Types of Doctor Loans

      • Business Loan for Doctors Personal Loan For Doctors Loan Against Property for Doctors Indemnity Insurance Medical Practice Loan
    • Medical Equipment Finance Apply Online
      • Overview Features Eligibility How to Apply Fees & Charges
    • Loans for CAs Apply Online Check Offer

        UNSECURED

      • Overview Features Eligibility How to Apply Fees & Charges Manage your Loans Manage your Flexi Loans
      • SECURED

      • Overview EMI Calculator Features Eligibility How to Apply Fees and charges Manage your loan
      • Types of CA Loans

      • Business Loan for Chartered Accountants Loan Against Property for Chartered Accountants Personal Loan for Chartered Accountants
    • Commercial Lending
      • Overview Term Loans Working Capital Products Corporate Lease Rental Discounting
    • Home Loan Apply Online Check Offer

        Home Loan

      • Home Loan World Overview Features EMI Calculator Eligibility How to Apply Fees and Charges Home Loan Interest Rate
      • Balance Transfer

      • Overview Features Eligibility How to Apply Fees and Charges
      • Categories

      • Home Loan for Doctors Home Loan for Self-employed Home Loan for Salaried
      • Categories

      • Home Loan Balance Transfer for Doctors Home Loan Balance Transfer for Self-employed Home Loan Balance Transfer for Salaried
    • Loan Against Property Apply Online

        LOAN AGAINST PROPERTY

      • Overview Features EMI Calculator Eligibility How to Apply Fees & Charges Loan Against Property Interest Rate
      • BALANCE TRANSFER

      • Overview Features Eligibility How to Apply Fees & Charges
    • Lease Rental Discounting
    • Loan Against Securities Apply Online

        LOAN AGAINST SHARES

      • Overview Features Eligibility How to Apply Fees & Charges Manage your Loan Against Securities FAQ
      • Loan Against Mutual Funds

      • Overview Features Eligibility How to Apply Fees & Charges FAQ
      • Loan Against Bonds

      • Overview Features and Benefits Eligibility How to Apply Fees and Charges FAQs
      • Loan Against Insurance Policy

      • Overview Features and Benefits Eligibility How to Apply Fees and Charges FAQs
      • ESOP Financing

      • Overview Features and Benefits Eligibility How to Apply Fees and Charges FAQs
    • Two-wheeler Loan Apply Online Check Offer
      • Overview Eligibility Features Interest Rates How to Apply Manage your Two-wheeler Loan FAQs
    • New Car Finance Apply Now Check Offer
      • Auto World Overview Features Eligibility How to Apply Interest Rates and Charges FAQs Manage your loan Manage your flexi loan
    • Used Car Loan Apply Now Check Offer

        Used Car Finance

      • Auto World Explore Used Cars and Loan Overview Features and benefits Eligibility EMI Calculator Used Car Loan Eligibility Calculator Fees and charges How to Apply FAQs Manage your loan Manage your flexi loan
      • Categories

      • Loan against car Car loan balance transfer
    • Loan Against Car Apply Now Check Offer

        Loan Against Car

      • Auto World Overview Features and benefits Eligibility EMI Calculator Loan Against Car Eligibility Calculator Fees and charges How to Apply FAQS Manage your loan Manage your flexi loan
      • Categories

      • Used car loan Car loan balance transfer
    • Car Loan Balance Transfer and Top-up Apply Now Check Offer

        Balance Transfer

      • Auto World Overview Features and benefits Eligibility EMI Calculator Car Loan Balance Transfer and Top Up Eligibility Calculator Fees and Charges How to Apply Manage your loan FAQS Manage your flexi loan
      • Categories

      • Used car loan Loan against car
    • Microfinance Group Loan
    • Tractor Loan
    • Loan for Lawyer
    • Easy EMI Loan
  • All on EMI
    • Electronics
    • Two-wheelers
    • Lifestyle
    • Travel
      • Our Partner Make My Trip Goibibo IRCTC
    • Shop on Ecommerce
      • Our Partner Flipkart Amazon
    • Offers & Promotions
    • Tractor
  • Bajaj Mall
    • Smartphones
    • Washing Machines
    • LED TVs
    • Refrigerators
    • Air Conditioners
    • Water Purifiers
    • Two-wheelers
    • Smartwatches
    • Laptops
    • Mattresses
    • Furniture
    • Kitchen Appliances
    • Cycles
    • Fitness Equipment
    • Air Cooler
    • Watches
    • Audio Devices
    • Camera Accessories
  • Card
    • Insta EMI Card Apply Online
      • Overview Features and Benefits Eligibility Fees and Charges How to Apply Manage your Insta EMI Card Contact Us
  • Investments
    • All Investments
    • Fixed Deposit Open FD
      • Overview FD Calculator Features and Benefits FD Interest Rates Eligibility and Documents How to Invest FAQs Manage your FD Contact Us
      • FIXED DEPOSIT FOR YOUR GOALS

        • Fixed Deposit for Retirement Fund
        • Fixed Deposit for Higher Education
        • Fixed Deposit for Home Expenses
        • Fixed Deposit for Wedding Expenses
    • Mutual Funds Open MF Account Explore Funds

        About the Product

      • SIP Calculator Overview Explore All MFs How to Invest FAQs Contact Us
      • Fund Category

      • Debt Funds Equity Funds Hybrid Funds ELSS Funds Thematic Funds Multi Cap Fund NFO Large Cap Mutual Funds Mid Cap Mutual Funds Small Cap Mutual Funds Liquid Mutual Funds Aggressive Hybrid Mutual Funds
      • Funds by Returns

      • 1 Month Returns 3 Months Returns 1 Year Returns 3 Years Returns Max Returns
      • Quick Links

      • Portfolio Order in progress Open mutual fund account Dashboard New Fund Offer (NFO)
    • Stock Trading Open A/C
      • Start Trading Open Demat Account Overview FAQ Contact Us
    • Partner Portal
    • Become Our Partner
  • Insurance
    • Insurance Mall
    • Health Insurance Explore Plans

        Health Insurance

      • Overview Get Quote FAQs
      • Family Health Insurance

      • Aditya Birla Group Activ Health Plan (ABCD) Bajaj Allianz Health Guard Insurance Plan ManipalCigna Pro-Health Group Niva Bupa Health Plus Plan Aditya Birla Active Assure Diamond
      • Top-up Health Insurance

      • Group Activ Health Super Top-Up Bajaj Allianz Extra care plus plan
      • Partners

      • Aditya Birla Health Insurance Bajaj Allianz General Insurance Niva Bupa Health Insurance Bajaj Finserv Health ManipalCigna Health Insurance
    • Car Insurance Explore Plans

        Car Insurance

      • Overview Get Quote FAQs
      • Partners

      • ACKO General Insurance Bajaj Allianz General Insurance SBI General Insurance
      • Comprehensive Car Insurance

      • ACKO Car Insurance Bajaj Allianz Car Insurance SBI General Car Insurance
      • Own Damage

      • Bajaj Allianz Car Insurance SBI General Car Insurance
    • Pocket Insurance Explore Plans

        Best Seller

      • Personal Accident Cover Group Activ Health Super top up Cover
      • Under 699

      • Cancer Secure Gym Injury Insurance Pregnancy Complications Cover Baggage Insurance
      • Health Must Have

      • Niva Bupa Health Plus Dental Cover Sports/Fitness Injury Fracture Cover Health Plus Hospital Cash
      • Monsoon Insurance

      • Dengue & Malaria Cover Monsoon Insurance Viral Fever(Infection) CPP Liv Protect Group Activ Secure Policy- Personal Accident Cover 18-55 Years
    • Investment Plans Explore Plans

        Investment Plans

      • Overview
      • Partners

      • HDFC Life Bajaj Allianz Life Insurance
      • Guaranteed Savings

      • HDFC Life Guaranteed Savings Plan Bajaj Allianz Life POS Goal Suraksha Plan
    • Life Insurance Explore Plans

        Life Insurance

      • Overview Get Quote
      • Partner

      • Bajaj Allianz Life Insurance HDFC Life insurance Future Generali India Life Insurance
    • Professional Indemnity Explore Now

        Professional Indemnity

      • Overview Get Quote Bajaj Allianz Professional Indemnity Insurance Plan View All
      • Partners

      • Bajaj Allianz General Insurance
    • Manage your Insurance
  • Payments
    • All Payments
    • Mobile Recharge Pay Now
      • Jio Airtel Vi BSNL
    • Electricity Bill Payment Pay Now
      • Maharashtra State Electricity Distbn Co Ltd West Bengal Electricity Torrent Power Tamil Nadu Electricity Board (TNEB) Central Power Distribution Corporation Ltd. of Andhra Pradesh (APCPDCL) Calcutta Electric Supply Corporation (CESC) Jaipur Vidyut Vitran Nigam (JVVNL) APEPDCL-Eastern Power Distribution CO AP Ltd South Bihar Power Distribution Company Ltd. Southern Power Distribution Co Ltd of Andhra Pradesh Purvanchal Vidyut Vitaran Nigam Limited
    • Gas Booking Pay Now
      • Indane Gas (Indian Oil) Bharat Gas (BPCL) HP Gas (HPCL)
    • Loan Repayment Pay Now
      • Bajaj Finance Limited Agent Collection DMI Finance Private Limited Annapurna Finance Private Limited-MFI Bajaj Auto Finance Ujjivan Small Finance Bank TVS Credit IIFL Finance Limited
    • FASTag Buy New Recharge
      • IDFC FIRST Bank - FASTag Airtel Payments Bank NETC FASTag ICICI Bank FASTag HDFC  Bank - FASTag State Bank of India - NETC FASTag Kotak Mahindra Bank - FASTag Axis Bank FASTag IndusInd Bank FASTag
    • DTH Pay Now
      • Dish TV Videocon D2H Airtel DTH Tata Sky Sun Direct TV
    • Credit Card Bill payment Pay Now
      • SBI Card RBL Bank Credit Card HDFC Bank Credit Card ICICI Bank Credit Card Axis Bank Credit Card DBS Credit Card BoB Credit Card IDFC FIRST Bank Credit Card Yes Bank Credit Card Kotak Mahindra Bank Credit Card AU Bank Credit Card
    • Bajaj Pay Wallet
    • Bajaj Pay Gift Card Buy Now
      • My Cards Gift Card Categories
    • Rewards
      • Rewards & Offers Flipkart Gift Card Redbus Gift Card Swiggy Gift Card Amazon Gift Card Zomato Gift Card
  • Offers
    • All Offers
    • Loans
    • Electronics and Appliances
    • Personal Loan
    • EMI Card
    • Investment
    • Business Loan
    • Lifestyle
    • Home Loan
    • Insurance
    • Doctor Loan
    • Two wheeler
    • CA Loan
    • Used Cars
    • Loan Against Securities
    • Broking
    • Rewards
    • Gold Loan
    • Payments
  • Services
    • Locate Us
      • Branches EMI Network Partner Stores Hospitals & Wellness Centres Insurance Network Hospitals Collection Centres
    • All Service Guides
    • Raise a Request
      • Overview Raise a Request Follow-up on an open request Re-open a closed request
    • Manage your Profile
      • Overview Contact Details Personal Details GST Details
    • Manage your Mandate
      • Overview Register Mandate Change Mandate
    • Repay your Loans
      • Overview Clear Overdue EMIs Pay Advance EMIs Part-prepay your Loans Foreclose your Loans Manage your loan settlement
    • Manage your Loans
      • Overview Consumer Durable Loans Flexi Loans Loan Against Fixed Deposit Loan Against Securities Gold Loan Two-wheeler Loan
    • Manage your Cards
      • Insta EMI card Health EMI Network Card
    • Manage your Investments
      • Fixed Deposit Systematic Deposit Plan
    • Manage your Insurance
      • Overview Policy Details Renew your Policy Claim your Policy Cancel your Policy Surrender your Policy
  • About Bajaj Finserv
    • Investor Relations
    • People and Committees
    • About Us
    • Impact
    • TICC
    • Careers
  • pay emi image Pay EMI
  • Do not call image Do not call
  • Download the app image Download the app
Sign In

Main Menu

  • Food & Grocery
    Main Menu
    Food & Grocery
    • Food & Beverages
    • Grocery
    • Fashion
    • Beauty & Personal Care
    • Health & Wellness
    • Home & Kitchen
  • Bajaj Pay
    Main Menu
    Bajaj Pay
    • Bajaj Pay
    • Wallet
    • Refer & Earn
    • Mobile Recharge
    • Buy FASTag
    • Bill Payments & Other Recharges
    • Add Money
  • Loans
    Main Menu
    Loans
    • Personal Loan
    • Gold Loan
    • Business Loan
    • Loan for Doctors
    • Home Loan
    • Secured Business Loan
    • Loan Against Property
    • Loan Against Shares
    • Loan for Chartered Accountants
    • Medical Equipment Finance
    • Loan Against Property Balance Transfer
    • Home Loan Balance Transfer
    • Loan Against Mutual Funds
    • Loan Against Bonds
    • Loan Against Insurance Policy
    • ESOP Financing
    • Two-wheeler Loan
    • Buy a Used Car
    • Tractor Loan
    • Used Car Loan
    • Loan Against Car
    • Car Loan Balance Transfer and Top-up
    • New Car Loan
    • Loan for Lawyer
    • Industrial Equipment Finance
    • Industrial Equipment Balance Transfer
    • Industrial Equipment Refinance
    • Easy EMI Loan
  • Electronics & Smartphones
    Main Menu
    Electronics & Smartphones
    • Smartphones
    • Air Conditioner
    • Led TVs
    • Air Coolers
    • Refrigerators
    • Washing Machines
    • Laptops
    • Easy EMI Loan
  • EMI Card
    Main Menu
    EMI Card
    • Insta EMI Card
  • Share Market
    Main Menu
    Share Market
    • Trading Account
    • Open Demat Account
    • Margin Trading Financing
    • Share Market
    • Invest in IPO
    • All stocks
    • Top gainers
    • Top losers
    • 52 week high
    • 52 week low
    • Loan against shares
  • MSME World
    Main Menu
    MSME World
    • Business Loan
    • Secured Business Loan
    • Loan against property
    • Loans against property balance transfer
    • Loan against shares
    • Home Loan
    • Loans against mutual funds
    • Loan against bonds
    • Loan against insurance policy
    • Industrial Equipment Finance
    • Industrial Equipment Balance Transfer
    • Industrial Equipment Refinance
  • Insurance
    Main Menu
    Insurance
    • Health Insurance
    • Term Life Insurance
    • ULIP Plan
    • Savings Plan
    • Retirement Plans
    • Child Plans
    • Investment Plans
    • Wallet Care
    • Waller Care Entertainment +
    • Personal Accident Care
    • EMI/SIP Cover
    • Health Prime Max
    • Fonesafe Lite
    • Mobile Protect
    • Wallet Protekt
    • Dengue Cover
    • Niva Bupa Health Plus
    • Health Plus Hospital Cash
    • Four Wheeler Insurance
  • Bajaj Prime
    Main Menu
    Bajaj Prime
    • Get Bajaj Prime
  • Investments
    Main Menu
    Investments
    • Fixed Deposit
    • Renew Fixed Deposit
    • ULIP Plan
    • Savings Plan
    • Retirement Plans
    • Child Plans
    • Free Demat Account
    • Invest in Stocks
    • Invest in IPO
    • Margin Trading Facility
    • Equity Mutual Funds
    • Debt Mutual Funds
    • Hybrid Mutual Funds
    • New Fund Offers
    • Open Mutual Fund Account
  • Gold Loan
    Main Menu
    Gold Loan
    • Apply for Gold Loan
    • Transfer your Gold Loan with Us
  • Two Wheeler World
    Main Menu
    Two Wheeler World
    • Bike
    • Scooter
    • Electric Vehicle
    • Best Sellers
    • Popular Brands
  • Credit Score
    Main Menu
    Credit Score
    • Check your Credit Score
  • Fun Zone
    Main Menu
    Fun Zone
    • Engagement Zone
    • Game Zone
  • Auto World
    Main Menu
    Auto World
    • New Car Loan
    • Used Car Loan
    • Loan Against Car
    • Car Loan Balance Transfer and Top-up
    • Buy a Used Car
  • Easy EMI Loan
    Main Menu
    Easy EMI Loan
    • Mobiles and Electronics on Easy EMI
  • Calculators
    Main Menu
    Calculators
    • Personal Loan EMI Calculator
    • Personal Loan Eligibility Calculator
    • Home Loan EMI Calculator
    • Home Loan Eligibility Calculator
    • Good & Service Tax (GST) Calculator
    • Flexi Day Wise Interest Calculator
    • Flexi Transaction Calculator
    • Secured Business Loan Eligibility Calculator
    • Fixed Deposits Interest Calculator
    • Two wheeler Loan EMI Calculator
    • New Car Loan EMI Calculator
    • Used Car Loan EMI Calculator
    • All Calculator
  • Lifestyle
    Main Menu
    Lifestyle
    • Hot Deals
    • Clearance Sale
    • Kitchen Appliances
    • Tyres
    • Camera & Accessories
    • Mattresses
    • Furniture
    • Watches
    • Music & Audio
    • Cycles
    • Mixer & Grinder
    • Luggage & Travel
    • Fitness Equipment
    • Fans
  • Doctor World
    Main Menu
    Doctor World
    • Personal Loan for Doctors
    • Business loan for Doctors
    • Medical Equipment Finance
    • Secured Business Loan
    • Loan against property
    • Loan against share
    • Gold Loan
    • Home Loan
  • All on EMI
    Main Menu
    All on EMI
    • Smartphones
    • Air Conditioners
    • LED TVs
    • Air Coolers
    • Refrigerators
    • Washing Machines
    • Laptops
    • Water Purifiers
    • Tablets
    • Kitchen Appliances
    • Mattresses
    • Furniture
    • Music and Audio
    • Cameras & Accessories
    • Cycle
    • Watches
    • Tyres
    • Luggage & Travel
    • Fitness Equipment
    • Tractor
    • Easy EMI Loan
  • Home Loan World
    Main Menu
    Home Loan World
    • Home Loan
    • Transfer your existing Home loan
    • Loan against Property
    • Home Loan for Salaried
    • Home loan for self employed
    • Home Loan EMI Calculator
    • Home Loan eligibility calculator
    • Home Loan balance transfer
  • Deals and Savings
    Main Menu
    Deals and Savings
    • Easy EMI
    • Offer World
    • 1 EMI OFF
    • New Launches
    • Zero Down Payment
    • Clearance Sale
    • Bajaj Mall Sale
  • Articles
    Main Menu
    Articles
    • Articles
  • Loan Payments
    Main Menu
    Loan Payments
    • Overdue Payments
    • Other Payments
  • Bank details/ Documents
    Main Menu
    Bank details/ Documents
    • Document Center
    • Bank details & Documents
    • Tax Invoice Certificate
  • Do Not Call Service
    Main Menu
    Do Not Call Service
    • Do Not Call Service
  • Your Things
    Main Menu
    Your Things
    • Your Orders
    • Hamara Mall Orders
  • Rewards
    Main Menu
    Rewards
    • Explore Bajaj Prime
    • Explore Rewards
    • Buy Deals & Gift cards
  • Partners
    Main Menu
    Partners
    • Fixed Deposit (IFA) Partner
    • Loan (DSA) Partner
    • Debt Management Partner
    • EMI Network Partner
    • Become a Merchant
    • Partner Sign-in
  • What's New
    Main Menu
    What's New
    • Food & Shopping
    • Credit Card Hub
    • ULIP Plans
    • Top Gainers Stock
    • Top Losers Stock
    • Saving Plan
    • Term Insurance
    • Easy EMI Loan
  • Watch Live
    Main Menu
    Watch Live
    • Live Videos
  • Help and Support
  • Settings
    Main Menu
    Settings
    • Update Profile
    • Manage Consent
    • Refer and Earn
    • About Us
    • Important Information
    • Terms of Service
    • Privacy Policy
    • Fair Practice Code
    • Citizen Charter
    • LogOut
    • TICC
  • Home
  • Account
  • More
  • Pay EMIs
  • Menu
Menu
Food & Grocery

Food & Grocery

  • Food & BeveragesFood & Beverages
  • GroceryGrocery
  • FashionFashion
  • Beauty & Personal CareBeauty & Personal Care
  • Health & WellnessHealth & Wellness
  • Home & KitchenHome & Kitchen
Bajaj Pay

Bajaj Pay

  • Bajaj PayBajaj Pay
  • WalletWallet
  • Refer & EarnRefer & Earn
  • Mobile RechargeMobile Recharge
  • Buy FASTagBuy FASTag
  • Bill Payments & Other RechargesBill Payments & Other Recharges
  • Add MoneyAdd Money
Loans

Loans

  • Personal LoanPersonal Loan
  • Gold LoanGold Loan
  • Business LoanBusiness Loan
  • Loan for DoctorsLoan for Doctors
  • Home LoanHome Loan
  • Secured Business LoanSecured Business Loan
  • Loan Against PropertyLoan Against Property
  • Loan Against SharesLoan Against Shares
  • Loan for Chartered AccountantsLoan for Chartered Accountants
  • Medical Equipment FinanceMedical Equipment Finance
  • Loan Against Property Balance TransferLoan Against Property Balance Transfer
  • Home Loan Balance TransferHome Loan Balance Transfer
  • Loan Against Mutual FundsLoan Against Mutual Funds
  • Loan Against BondsLoan Against Bonds
  • Loan Against Insurance PolicyLoan Against Insurance Policy
  • ESOP FinancingESOP Financing
  • Two-wheeler LoanTwo-wheeler Loan
  • Buy a Used CarBuy a Used Car
  • Tractor LoanTractor Loan
  • Used Car LoanUsed Car Loan
  • Loan Against CarLoan Against Car
  • Car Loan Balance Transfer and Top-upCar Loan Balance Transfer and Top-up
  • New Car LoanNew Car Loan
  • Loan for LawyerLoan for Lawyer
  • Industrial Equipment FinanceIndustrial Equipment Finance
  • Industrial Equipment Balance TransferIndustrial Equipment Balance Transfer
  • Industrial Equipment RefinanceIndustrial Equipment Refinance
  • Easy EMI LoanEasy EMI Loan
Electronics & Smartphones

Electronics & Smartphones

  • SmartphonesSmartphones
  • Air ConditionerAir Conditioner
  • Led TVsLed TVs
  • Air CoolersAir Coolers
  • RefrigeratorsRefrigerators
  • Washing MachinesWashing Machines
  • LaptopsLaptops
  • Easy EMI LoanEasy EMI Loan
EMI Card

EMI Card

  • Insta EMI CardInsta EMI Card
Share Market

Share Market

  • Trading AccountTrading Account
  • Open Demat AccountOpen Demat Account
  • Margin Trading FinancingMargin Trading Financing
  • Share MarketShare Market
  • Invest in IPOInvest in IPO
  • All stocksAll stocks
  • Top gainersTop gainers
  • Top losersTop losers
  • 52 week high52 week high
  • 52 week low52 week low
  • Loan against sharesLoan against shares
msme-world

MSME World

  • Business LoanBusiness Loan
  • Secured Business LoanSecured Business Loan
  • Loan against propertyLoan against property
  • Loans against property balance transferLoans against property balance transfer
  • Loan against sharesLoan against shares
  • Home LoanHome Loan
  • Loans against mutual fundsLoans against mutual funds
  • Loan against bondsLoan against bonds
  • Loan against insurance policyLoan against insurance policy
  • Industrial Equipment FinanceIndustrial Equipment Finance
  • Industrial Equipment Balance TransferIndustrial Equipment Balance Transfer
  • Industrial Equipment RefinanceIndustrial Equipment Refinance
Insurance

Insurance

  • Health InsuranceHealth Insurance
  • Term Life InsuranceTerm Life Insurance
  • ULIP PlanULIP Plan
  • Savings PlanSavings Plan
  • Retirement PlansRetirement Plans
  • Child PlansChild Plans
  • Investment PlansInvestment Plans
  • Wallet CareWallet Care
  • Waller Care Entertainment +Waller Care Entertainment +
  • Personal Accident CarePersonal Accident Care
  • EMI/SIP CoverEMI/SIP Cover
  • Health Prime MaxHealth Prime Max
  • Fonesafe LiteFonesafe Lite
  • Mobile ProtectMobile Protect
  • Wallet ProtektWallet Protekt
  • Dengue CoverDengue Cover
  • Niva Bupa Health PlusNiva Bupa Health Plus
  • Health Plus Hospital CashHealth Plus Hospital Cash
  • Four Wheeler InsuranceFour Wheeler Insurance
Bajaj Prime

Bajaj Prime

  • Get Bajaj PrimeGet Bajaj Prime
Investments

Investments

  • Fixed DepositFixed Deposit
  • Renew Fixed DepositRenew Fixed Deposit
  • ULIP PlanULIP Plan
  • Savings PlanSavings Plan
  • Retirement PlansRetirement Plans
  • Child PlansChild Plans
  • Free Demat AccountFree Demat Account
  • Invest in StocksInvest in Stocks
  • Invest in IPOInvest in IPO
  • Margin Trading FacilityMargin Trading Facility
  • Equity Mutual FundsEquity Mutual Funds
  • Debt Mutual FundsDebt Mutual Funds
  • Hybrid Mutual FundsHybrid Mutual Funds
  • New Fund OffersNew Fund Offers
  • Open Mutual Fund AccountOpen Mutual Fund Account
Gold Loan

Gold Loan

  • Apply for Gold LoanApply for Gold Loan
  • Transfer your Gold Loan with UsTransfer your Gold Loan with Us
Two Wheeler World

Two Wheeler World

  • BikeBike
  • ScooterScooter
  • Electric VehicleElectric Vehicle
  • Best SellersBest Sellers
  • Popular BrandsPopular Brands
Credit Score

Credit Score

  • Check your Credit ScoreCheck your Credit Score
Fun Zone

Fun Zone

  • Engagement ZoneEngagement Zone
  • Game ZoneGame Zone
Auto World

Auto World

  • New Car LoanNew Car Loan
  • Used Car LoanUsed Car Loan
  • Loan Against CarLoan Against Car
  • Car Loan Balance Transfer and Top-upCar Loan Balance Transfer and Top-up
  • Buy a Used CarBuy a Used Car
Easy EMI Loan

Easy EMI Loan

  • Mobiles and Electronics on Easy EMIMobiles and Electronics on Easy EMI
Calculators

Calculators

  • Personal Loan EMI CalculatorPersonal Loan EMI Calculator
  • Personal Loan Eligibility CalculatorPersonal Loan Eligibility Calculator
  • Home Loan EMI CalculatorHome Loan EMI Calculator
  • Home Loan Eligibility CalculatorHome Loan Eligibility Calculator
  • Good & Service Tax (GST) CalculatorGood & Service Tax (GST) Calculator
  • Flexi Day Wise Interest CalculatorFlexi Day Wise Interest Calculator
  • Flexi Transaction CalculatorFlexi Transaction Calculator
  • Secured Business Loan Eligibility CalculatorSecured Business Loan Eligibility Calculator
  • Fixed Deposits Interest CalculatorFixed Deposits Interest Calculator
  • Two wheeler Loan EMI CalculatorTwo wheeler Loan EMI Calculator
  • New Car Loan EMI CalculatorNew Car Loan EMI Calculator
  • Used Car Loan EMI CalculatorUsed Car Loan EMI Calculator
  • All CalculatorAll Calculator
Lifestyle

Lifestyle

  • Hot DealsHot Deals
  • Clearance SaleClearance Sale
  • Kitchen AppliancesKitchen Appliances
  • TyresTyres
  • Camera & AccessoriesCamera & Accessories
  • MattressesMattresses
  • FurnitureFurniture
  • WatchesWatches
  • Music & AudioMusic & Audio
  • CyclesCycles
  • Mixer & GrinderMixer & Grinder
  • Luggage & TravelLuggage & Travel
  • Fitness EquipmentFitness Equipment
  • FansFans
Doctor World

Doctor World

  • Personal Loan for DoctorsPersonal Loan for Doctors
  • Business loan for DoctorsBusiness loan for Doctors
  • Medical Equipment FinanceMedical Equipment Finance
  • Secured Business LoanSecured Business Loan
  • Loan against propertyLoan against property
  • Loan against shareLoan against share
  • Gold LoanGold Loan
  • Home LoanHome Loan
All on EMI

All on EMI

  • SmartphonesSmartphones
  • Air ConditionersAir Conditioners
  • LED TVsLED TVs
  • Air CoolersAir Coolers
  • RefrigeratorsRefrigerators
  • Washing MachinesWashing Machines
  • LaptopsLaptops
  • Water PurifiersWater Purifiers
  • TabletsTablets
  • Kitchen AppliancesKitchen Appliances
  • MattressesMattresses
  • FurnitureFurniture
  • Music and AudioMusic and Audio
  • Cameras & AccessoriesCameras & Accessories
  • CycleCycle
  • WatchesWatches
  • TyresTyres
  • Luggage & TravelLuggage & Travel
  • Fitness EquipmentFitness Equipment
  • TractorTractor
  • Easy EMI LoanEasy EMI Loan
Home Loan World

Home Loan World

  • Home LoanHome Loan
  • Transfer your existing Home loanTransfer your existing Home loan
  • Loan against PropertyLoan against Property
  • Home Loan for SalariedHome Loan for Salaried
  • Home loan for self employedHome loan for self employed
  • Home Loan EMI CalculatorHome Loan EMI Calculator
  • Home Loan eligibility calculatorHome Loan eligibility calculator
  • Home Loan balance transferHome Loan balance transfer
Deals and Savings

Deals and Savings

  •  Easy EMI Easy EMI
  • Offer WorldOffer World
  • 1 EMI OFF1 EMI OFF
  • New LaunchesNew Launches
  • Zero Down PaymentZero Down Payment
  • Clearance SaleClearance Sale
  • Bajaj Mall SaleBajaj Mall Sale
Articles

Articles

  • ArticlesArticles
Loan Payments

Loan Payments

  • Overdue PaymentsOverdue Payments
  • Other PaymentsOther Payments
Bank details/ Documents

Bank details/ Documents

  • Document CenterDocument Center
  • Bank details & DocumentsBank details & Documents
  • Tax Invoice CertificateTax Invoice Certificate
Do Not Call Service

Do Not Call Service

  • Do Not Call ServiceDo Not Call Service
Your Things

Your Things

  • Your OrdersYour Orders
  • Hamara Mall OrdersHamara Mall Orders
Rewards

Rewards

  • Explore Bajaj PrimeExplore Bajaj Prime
  • Explore RewardsExplore Rewards
  • Buy Deals & Gift cardsBuy Deals & Gift cards
Partners

Partners

  • Fixed Deposit (IFA) PartnerFixed Deposit (IFA) Partner
  • Loan (DSA) PartnerLoan (DSA) Partner
  • Debt Management PartnerDebt Management Partner
  • EMI Network PartnerEMI Network Partner
  • Become a MerchantBecome a Merchant
  • Partner Sign-inPartner Sign-in
What's New

What's New

  •  Food & Shopping Food & Shopping
  • Credit Card HubCredit Card Hub
  • ULIP PlansULIP Plans
  • Top Gainers StockTop Gainers Stock
  • Top Losers StockTop Losers Stock
  • Saving PlanSaving Plan
  • Term InsuranceTerm Insurance
  • Easy EMI LoanEasy EMI Loan
Watch Live

Watch Live

  • Live VideosLive Videos
Help and Support
Settings
Update Profile Manage Consent Refer and Earn About Us Important Information Terms of Service Privacy Policy Fair Practice Code Citizen Charter LogOut TICC
Relations Documents Profile Loan Payments

Error

400

We are sorry.

There's nothing here yet.

BACK TO HOMEPAGE
  • Overview
  • Performance
  • Fundamentals
  • Financials
  • Technical summary
  • Shareholding pattern
  • About
  • View more stocks
  • All stocks
  • Top gainers
  • Top losers
  • FAQs

STRIDES PHARMA SCI LTD

STAR

NSE

BSE

Pharmaceuticals

₹ 660.65

-5.04 -0.75%

OPEN DEMAT ACCOUNT

Stock price as on May 16 2025 01:51 PM

Stock performance

Performance

Company fundamentals

Fundamentals

Company financials

Financials

Stock technical summary

Technical summary

Company shareholding pattern

Shareholding pattern

About

About {Company_Name}

Similar stocks

Similar stocks

FAQs

FAQs

Performance Graph
YTD 1 Week 1 Months 3 Months 6 Months 1 Year -0.75% 4.79% 7.47% 7.31% 11.19% 73.58%

Strides Pharma Sci Ltd stock performance

Today’s low

656.5

Today’s high

675.0

660.65

52 week low

513.05

52 week high

1675.0

662.0

Open

669.0

Previous close

665.7

Share volume

147240.0

Total traded value (Lakh)

974.72

Upper circuit

798.8

Lower circuit

532.6

Stock performance

This data indicates the stock's performance over a specific period, measured by tracking its price movements.

<p><b>Open</b></p> <p style="text-align: left;">The price at which a stock begins trading at the start of the trading day.<br /> </p> <p> </p> <p><b>Previous close</b></p> <p style="text-align: left;">The price at which a stock ended trading on the previous day.<br /> </p> <p> </p> <p><b>Share volume</b></p> <p style="text-align: left;">The total number of shares  traded during a specific period, typically within a trading day.</p> <p> </p> <p><b>Trade value</b></p> <p>The total value of all trades made during a specific period.<br /> </p> <p> </p> <p><b>Upper circuit</b></p> <p>The maximum allowed price increase in a stock during a single session, after which trading is temporarily paused.</p> <p> </p> <p><b>Lower circuit</b></p> <p>The maximum allowed price decrease in a stock during a single session, after which trading is temporarily paused.</p> <p> </p>

Strides Pharma Sci Ltd fundamentals

Market cap (Cr)
6071.35
P/E ratio (TTM)
69.49
Book value per share
₹ 0.0
Beta
0.96
Return on equity
1.87
Earnings per share (TTM)
₹ 9.59
Dividend yield
0.37%
Net profit/quarter (Cr)
₹ 14.94

Fundamentals

Understand the common terms associated with a company's stock fundamentals

<p><b>Market cap</b></p> <p>The total value of a company's outstanding shares, calculated by multiplying the current stock price with the number of shares.<br> </p> <p>&nbsp;</p> <p><b>P/E ratio (TTM)</b></p> <p style="text-align: left;">The price-to-earnings ratio, showing how investors value a company by dividing the stock price by earnings per share (EPS).<br> </p> <p>&nbsp;</p> <p><b>Book value per share</b></p> <p style="text-align: left;">The value of a company per share, calculated by dividing the company's net assets by the total number of shares.</p> <p style="text-align: left;">&nbsp;</p> <p><b>Beta</b></p> <p>A measure of a stock’s volatility compared to the&nbsp; market:</p> <p>&nbsp;</p> <p>Beta of 1: Stock moves with the market.</p> <p>Beta &gt; 1: More volatile.</p> <p>Beta &lt; 1: Less volatile.</p> <p>&nbsp;</p> <p><b>Return on equity</b></p> <p style="text-align: left;">Indicates how profitable a company is compared to shareholder investment, calculated by dividing net income by shareholders' equity.<br> </p> <p>&nbsp;</p> <p><b>Earnings per share (TTM)</b></p> <p>The profit earned per share over the past 12 months.<br> </p> <p>&nbsp;</p> <p><b>Dividend yield</b></p> <p>The return on investment from dividends, calculated by dividing the annual dividend by the current share price.</p> <p>&nbsp;</p> <p><b>Net profit/quarter</b></p> <p>The profit a company makes in a quarter after all expenses and taxes are deducted.</p> <p>&nbsp;</p>

Strides Pharma Sci Ltd financials

(Values in Cr)

Revenue

Net income

Revenue

Particulars

202412 (₹ value in crores)

Revenue

550.92

Operating expense

531.95

Net income

14.94

Net profit margin

2.71%

Earnings per share

1.62

EBITDA

76.51

Effective tax rate

30.12
Revenue

Particulars

202409 (₹ value in crores)

Revenue

519.55

Operating expense

526.71

Net income

17.26

Net profit margin

3.32%

Earnings per share

1.88

EBITDA

78.91

Effective tax rate

-5.37
Revenue

Particulars

202406 (₹ value in crores)

Revenue

585.95

Operating expense

590.48

Net income

2.4

Net profit margin

0.4%

Earnings per share

0.26

EBITDA

73.86

Effective tax rate

32.77
Revenue

Particulars

202403 (₹ value in crores)

Revenue

617.63

Operating expense

594.42

Net income

53.66

Net profit margin

8.68%

Earnings per share

5.84

EBITDA

120.36

Effective tax rate

-1.68
Revenue

Particulars

202312 (₹ value in crores)

Revenue

379.64

Operating expense

435.93

Net income

-0.38

Net profit margin

-0.1%

Earnings per share

-0.04

EBITDA

1.07

Effective tax rate

-6.35

(Values in Cr)

Revenue

Net income

Revenue Annual

Particulars

202403 (₹ value in crores)

Revenue

1866.12

Operating expense

1942.4

Net income

44.55

Net profit margin

2.38%

Earnings per share

4.89

EBITDA

203.85

Effective tax rate

-5.84
Revenue Annual

Particulars

202303 (₹ value in crores)

Revenue

1854.5

Operating expense

1988.32

Net income

4.68

Net profit margin

0.25%

Earnings per share

0.52

EBITDA

167.54

Effective tax rate

107.22
Revenue Annual

Particulars

202203 (₹ value in crores)

Revenue

1979.0

Operating expense

2080.98

Net income

180.19

Net profit margin

9.1%

Earnings per share

20.08

EBITDA

200.12

Effective tax rate

-737.7
Revenue Annual

Particulars

202103 (₹ value in crores)

Revenue

1857.57

Operating expense

1834.92

Net income

78.24

Net profit margin

4.21%

Earnings per share

8.73

EBITDA

276.32

Effective tax rate

29.91
Revenue Annual

Particulars

202003 (₹ value in crores)

Revenue

1691.93

Operating expense

1648.56

Net income

120.28

Net profit margin

7.1%

Earnings per share

13.43

EBITDA

297.53

Effective tax rate

11.85

Financials

<p><b>Quarterly</b>: Months listed along the bottom of the graph represent a quarter.</p> <p><b>Annual</b>: Months listed along the bottom of the graph represent a financial year.<br /> </p>

ROE

ROCE

Consolidated Ratios

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

231.28

Return on Equity (ROE)

0.0

Return on Capital Employed (ROCE)

0.0

Total debt to equity ratio

1.28

EBITDA margin

14.93
Consolidated Ratios

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

243.09

Return on Equity (ROE)

0.0

Return on Capital Employed (ROCE)

0.0

Total debt to equity ratio

1.32

EBITDA margin

6.42
Consolidated Ratios

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

262.7

Return on Equity (ROE)

-9.42

Return on Capital Employed (ROCE)

-4.44

Total debt to equity ratio

1.05

EBITDA margin

-0.34
Consolidated Ratios

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

309.62

Return on Equity (ROE)

8.14

Return on Capital Employed (ROCE)

7.59

Total debt to equity ratio

0.86

EBITDA margin

18.06
Consolidated Ratios

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

282.19

Return on Equity (ROE)

3.13

Return on Capital Employed (ROCE)

4.9

Total debt to equity ratio

1.05

EBITDA margin

16.34

ROE

ROCE

Satandalone Data

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

387.49

Return on Equity (ROE)

1.87

Return on Capital Employed (ROCE)

4.68

Total debt to equity ratio

0.44

EBITDA margin

14.96
Satandalone Data

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

380.71

Return on Equity (ROE)

0.61

Return on Capital Employed (ROCE)

1.87

Total debt to equity ratio

0.39

EBITDA margin

9.91
Satandalone Data

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

379.36

Return on Equity (ROE)

5.29

Return on Capital Employed (ROCE)

1.87

Total debt to equity ratio

0.33

EBITDA margin

9.57
Satandalone Data

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

362.18

Return on Equity (ROE)

2.44

Return on Capital Employed (ROCE)

4.18

Total debt to equity ratio

0.28

EBITDA margin

14.88
Satandalone Data

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

352.68

Return on Equity (ROE)

3.75

Return on Capital Employed (ROCE)

4.98

Total debt to equity ratio

0.27

EBITDA margin

17.59

Financials

<p>Months listed along the bottom of the graph represent a financial year.<br /> </p> <p>         </p> <p><b>Consolidated</b>: Data of the entire group of companies.</p> <p><b>Standalone</b>: Data of the single company.<br /> </p>

(Values in Cr)

Consolidated Balance Sheet

Particulars

Mar 24 (₹ value in crores)

Cash and short-term investments

191.16

5839.75

5839.75

Total Equity

2071.7

Shares Outstanding

91899714

Price to book ratio

2.02

Return on assets (%)

-1.2

Return on capital (%)

-1.57
Consolidated Balance Sheet

Particulars

Mar 24 (₹ value in crores)

Cash and short-term investments

315.96

6638.42

6638.42

Total Equity

2172.88

Shares Outstanding

90302704

Price to book ratio

0.75

Return on assets (%)

-3.05

Return on capital (%)

-4.1
Consolidated Balance Sheet

Particulars

Mar 24 (₹ value in crores)

Cash and short-term investments

187.35

6975.86

6975.86

Total Equity

2383.31

Shares Outstanding

89790214

Price to book ratio

0.91

Return on assets (%)

-6.59

Return on capital (%)

-8.89
Consolidated Balance Sheet

Particulars

Mar 24 (₹ value in crores)

Cash and short-term investments

179.76

7015.02

7015.02

Total Equity

2814.0

Shares Outstanding

89680964

Price to book ratio

2.33

Return on assets (%)

3.82

Return on capital (%)

5.46
Consolidated Balance Sheet

Particulars

Mar 24 (₹ value in crores)

Cash and short-term investments

237.09

6151.73

6151.73

Total Equity

2594.65

Shares Outstanding

89565464

Price to book ratio

0.91

Return on assets (%)

0.59

Return on capital (%)

0.82

(Values in Cr)

Standalone Balance Sheet

Particulars

Mar 24 (₹ value in crores)

Cash and short-term investments

111.83

5837.78

5837.78

Total Equity

3561.12

Shares Outstanding

91899714

Price to book ratio

2.02

Return on assets (%)

1.12

Return on capital (%)

1.27
Standalone Balance Sheet

Particulars

Mar 24 (₹ value in crores)

Cash and short-term investments

85.58

5619.74

5619.74

Total Equity

3455.05

Shares Outstanding

90302704

Price to book ratio

0.75

Return on assets (%)

0.08

Return on capital (%)

0.1
Standalone Balance Sheet

Particulars

Mar 24 (₹ value in crores)

Cash and short-term investments

14.44

5433.85

5433.85

Total Equity

3406.68

Shares Outstanding

89790214

Price to book ratio

0.91

Return on assets (%)

3.31

Return on capital (%)

3.87
Standalone Balance Sheet

Particulars

Mar 24 (₹ value in crores)

Cash and short-term investments

73.04

5221.33

5221.33

Total Equity

3248.05

Shares Outstanding

89680964

Price to book ratio

2.33

Return on assets (%)

1.49

Return on capital (%)

1.9
Standalone Balance Sheet

Particulars

Mar 24 (₹ value in crores)

Cash and short-term investments

109.89

4676.86

4676.86

Total Equity

3158.78

Shares Outstanding

89565464

Price to book ratio

0.91

Return on assets (%)

2.57

Return on capital (%)

3.0

Financials

<p>Months listed along the bottom of the graph represent a financial year.</p> <p> </p> <p><b>Consolidated</b>: Data of the entire group of companies.</p> <p><b>Standalone</b>: Data of a single company.<br /> </p>

(Values in Cr)

Net income

Net change

Consolidated Cash Flow

Particulars

Mar 24 (₹ value in crores)

-62.72

Cash from operations

676.81

Cash from investing

-150.25

Cash from financing

-693.32

Net change in cash

-142.5

Free cash flow

794.96
Consolidated Cash Flow

Particulars

Mar 24 (₹ value in crores)

-267.63

Cash from operations

-43.23

Cash from investing

302.47

Cash from financing

-213.92

Net change in cash

132.96

Free cash flow

51.7
Consolidated Cash Flow

Particulars

Mar 24 (₹ value in crores)

-652.51

Cash from operations

-260.14

Cash from investing

-118.73

Cash from financing

421.31

Net change in cash

44.76

Free cash flow

-116.75
Consolidated Cash Flow

Particulars

Mar 24 (₹ value in crores)

289.38

Cash from operations

324.64

Cash from investing

-520.82

Cash from financing

-15.79

Net change in cash

-55.18

Free cash flow

622.12
Consolidated Cash Flow

Particulars

Mar 24 (₹ value in crores)

48.5

Cash from operations

249.76

Cash from investing

1306.15

Cash from financing

-1709.44

Net change in cash

-198.5

Free cash flow

399.76

(Values in Cr)

Net income

Net change

Standalone Cash Flow

Particulars

Mar 24 (₹ value in crores)

69.62

Cash from operations

-89.46

Cash from investing

-61.26

Cash from financing

107.62

Net change in cash

10.6

Free cash flow

-22.17
Standalone Cash Flow

Particulars

Mar 24 (₹ value in crores)

-64.76

Cash from operations

141.92

Cash from investing

-182.57

Cash from financing

10.81

Net change in cash

69.98

Free cash flow

222.6
Standalone Cash Flow

Particulars

Mar 24 (₹ value in crores)

21.5

Cash from operations

-304.09

Cash from investing

18.77

Cash from financing

250.73

Net change in cash

-13.17

Free cash flow

-235.92
Standalone Cash Flow

Particulars

Mar 24 (₹ value in crores)

111.63

Cash from operations

115.97

Cash from investing

-275.64

Cash from financing

-48.63

Net change in cash

-41.51

Free cash flow

204.71
Standalone Cash Flow

Particulars

Mar 24 (₹ value in crores)

136.44

Cash from operations

169.81

Cash from investing

62.83

Cash from financing

-203.55

Net change in cash

-3.09

Free cash flow

240.28

Financials

<p>Months listed along the bottom of the graph represent a financial year.</p> <p> </p> <p><b>Consolidated</b>: Data of the entire group of companies.</p> <p><b>Standalone</b>: Data of a single company.<br /> </p>

Company name

Price

P/E

P/B

Market cap

52 week low/high

38.18

20.53

2.08

292.59

34.11 / 77.7

120.45

15.06

1.2

1269.18

92.25 / 184.95

1502.25

23.01

3.88

121327.78

1310.05 / 1702.0

288.75

23.92

2.92

849.82

145.0 / 449.0

₹38.18

23.0

6.49

292.59

34.11 / 77.7

₹717.35

42.05

6.96

2073.9

548.05 / 861.4

₹7947.6

118.53

29.24

19869.0

5403.0 / 9199.0

₹120.45

18.39

1.19

1269.18

92.25 / 184.95

Strides Pharma Sci Ltd technical summary

662.0-0.55
0
16
Bullish
659.1
655.3
654.4
652.0
651.0
649.2
643.8
602.3
656.8
652.0
651.8
654.8
642.6
643.1
650.5
633.4
663.23
PIVOT
First support656.87
Second support648.03
Third support₹641.67
RSI53.94
MACD3.44%
Commodity Channel Index (CCI)₹62.53
First resistance672.07
Second resistance678.43
Third resistance-687.27
ADX3.37
Williams % R-36.63
Date2025-05-15
Same day136899
Week114632
Month145437
1 year
73.58
3 years
72.47
Price change analysis
-4.79%
Over 1 month
-7.47%
Over 3 month
-7.31%
Over 6 month
-11.19%
Over 3 year
72.47%
Over 6 year
29.54%

Strides Pharma Sci Ltd shareholding pattern

Holding %

Public

29.66%

Promoter holdings

28.29%

FII

28.32%

DII

13.71%

Promoter shares

51.98%

Promoter shares

Pronomz Ventures Llp

Quant Mutual Fund - Quant Business Cycle Fund

Route One Offshore Master Fund, L.p.

Karuna Business Solutions Llp

Arun Kumar Pillai

Route One Fund I, L.p.

Sbi Life Insurance Co. Ltd

Morgan Stanley Asia (singapore) Pte. - Odi

Satpal Khattar

K R Ravishankar

Bnp Paribas Financial Markets - Odi

Axis Mutual Fund Trustee Limited A/caxis Mutual F

Mukul Mahavir Agrawal

Authum Investment And Infrastructure Limited

Oman India Joint Investment Fund Ii

Vanguard Total International Stock Index Fund

Agraganya Private Trust (trustee: Barclay Wealth Trustees (i) Pvt Ltd)

Ambemata Securities (vimalkumar Srisrimal)

Vineetha Mohanakumar Pillai

Padmakumar Karunakaran Pillai

Shasun Enterprises Llp (formerly, Devendra Estates Llp)

K R Lakshmi

Sajitha Pillai

Hemalatha Pillai

Rajitha Gopalakrishnan

Aditya Arun Kumar

Anuradha K R

Triumph Venture Holdings Llp

Karuna Ventures Private Limited

Chayadeep Properties Private Ltd

Agnus Holdings Pvt Ltd

Agnus Capital Llp

Abusha Investment & Manangement Services Llp

Shasun Leasing And Finance (p) Limited

Tarini Arun Kumar

Rajeswari Amma

Deepa Arun Kumar

Share

Category

18046585
(19.58)%

Shareholding of Promoter and Promoter Group

4977936
(5.4)%

Public Shareholding

4653310
(5.05)%

Public Shareholding

3225050
(3.5)%

Shareholding of Promoter and Promoter Group

2060687
(2.24)%

Shareholding of Promoter and Promoter Group

1997344
(2.17)%

Public Shareholding

1929039
(2.09)%

Public Shareholding

1862447
(2.02)%

Public Shareholding

1474942
(1.6)%

Public Shareholding

1255593
(1.36)%

Shareholding of Promoter and Promoter Group

1207237
(1.31)%

Public Shareholding

1142575
(1.24)%

Public Shareholding

1066000
(1.16)%

Public Shareholding

1020068
(1.11)%

Public Shareholding

1011103
(1.1)%

Public Shareholding

948609
(1.03)%

Public Shareholding

300000
(0.33)%

Shareholding of Promoter and Promoter Group

240860
(0.26)%

Shareholding of Promoter and Promoter Group

190000
(0.21)%

Shareholding of Promoter and Promoter Group

186485
(0.2)%

Shareholding of Promoter and Promoter Group

156451
(0.17)%

Shareholding of Promoter and Promoter Group

130482
(0.14)%

Shareholding of Promoter and Promoter Group

95000
(0.1)%

Shareholding of Promoter and Promoter Group

66760
(0.07)%

Shareholding of Promoter and Promoter Group

60000
(0.07)%

Shareholding of Promoter and Promoter Group

58422
(0.06)%

Shareholding of Promoter and Promoter Group

5470
(0.01)%

Shareholding of Promoter and Promoter Group

0
(0)%

Shareholding of Promoter and Promoter Group

0
(0)%

Shareholding of Promoter and Promoter Group

0
(0)%

Shareholding of Promoter and Promoter Group

0
(0)%

Shareholding of Promoter and Promoter Group

0
(0)%

Shareholding of Promoter and Promoter Group

0
(0)%

Shareholding of Promoter and Promoter Group

0
(0)%

Shareholding of Promoter and Promoter Group

0
(0)%

Shareholding of Promoter and Promoter Group

0
(0)%

Shareholding of Promoter and Promoter Group

0
(0)%

Shareholding of Promoter and Promoter Group

About Strides Pharma Sci Ltd

Strides Pharma Science Limited was originally incorporated under the name 'Strides Arcolab Limited ' on June 28, 1990. In FY 2016, Shasun Pharmaceuticals Limited merged with Strides Arcolab Limited forming a new identity 'Strides Shasun Limited', which became effective from 19 November, 2015 and name of the Company was changed to 'Strides Pharma Science Limited' from 'Strides Shasun Limited' effective on July 18, 2018. Strides Pharma Science is a global pharmaceutical company headquartered in Bengaluru, India. The Company is an integrated manufacturer and exporter of Finished Pharmaceutical Dosage forms for both branded and generic. It manufactures a very wide spectrum of ethical pharmaceutical products, OTC products and nutraceuticals. Their dosage forms range includes tablets, capsules, soft gelatin capsules, parenterals and semisolids. They undertake contract research and manufacturing of specialty chemicals. The Company has a global manufacturing footprint with 8 production units spread across three continents, of which, 6 manufacturing facilities cater to regulated markets and have key regulatory approvals including USFDA, UK MHRA, TGA, PMDA ANVISA, WHO. It own 2 dedicated production facilities for their emerging markets. It operates in more than 100 nations. During the year 1999-2000, the company established Pentagon Exim, a 100% subsidiary in UAE to accelerate entry into new markets. They incorporated Strides Inc, a 100% subsidiary in USA. The company also acquired the toll manufacturing company, namely Caryl Laboratories Ltd during the year. During the year 2001-02, Bombay Drugs & Pharmaceuticals Ltd was amalgamated with the company. The company also acquired 51% stake in Infabra Industria Farmaceutica Brasileria Ltda, Brazil. Arcolab SA, Switzerland became a wholly owned subsidiary of the company during the year. During the year 2002-03, the company signed an MoU with Ribbon SRL Italy for setting up a 50:50 joint venture to manufacture and market Cephalosporin formulations for the regulated markets. Strides Latina, Uruguay and Strides Research & Specialty Chemicals Ltd became the subsidiaries of the company. The company transferred the Contract Research and Manufacturing Division (CRAM) to their wholly owned subsidiary, Strides Research & Specialty Chemicals Ltd with effect from April 1, 2002. During the year 2003-04, the Latam operations in Brazil and Mexico operations were merged into Strides Latina and the company entered into strategic agreement with Latam partners to acquire controlling stake. They also commenced production in their Solid Dosage facility in Vittoria, Brazil to cater to domestic demand. Caryl Laboratories Ltd, a wholly owned subsidiary of the company was amalgamated with Global Remedies Ltd another wholly owned subsidiary of the company. During the year, the company set up a 50: 50 Joint Venture in collaboration with Akorn Inc, US to market products for the hospital and retail market in the US. The company also incorporated Quantum Life Sciences Pvt Ltd as a 100% subsidiary for implementation of their Cephalosporin Project at Bangalore. In the year 2005, the company established a new technology centre christened STAR-Strides Technology and Research. Also, they expanded the Anti TB Facility at KRS Gardens, Bangalore. The company increased their stake in Strides Latina SA, Uruguay from 40% to 52.5%% in February 2005 and further increased to 67% in May 2005. In May 2005, the company acquired 90% stake in Medgene Pharmaceuticals Pvt Ltd, a Hyderabad based biotech and biopharmaceuticals company at a cost of 5.25 million. In December 2005, the company acquired Strides Arcolab (UK) Ltd in the UK at a cost of GBP 1000. In the year 2006, the company through their wholly owned subsidiary, Strides Arcolab International Ltd acquired 70% stake in Beltapharm SpA, Italy, a pharmaceutical manufacturer and 100% stake in Fabryka na Daniszewskiej sp.z o.o., (later renamed as Strides Arcolab Polska sp.z o.o.,) the Polish manufacturing facility of ICN Valeant. The company acquired 100% stake in Drug Houses of Australia (Asia) Pvt Ltd, a leading player of branded generic pharmaceutical products in Singapore with presence in Malaysia and Hong Kong. This acquisition was made through Strides Singapore Pte Ltd, a wholly owned subsidiary of Strides Arcolab International Ltd, UK. During the year, the company entered into a definite agreement with Accu-Break Pharmaceuticals Inc, USA to set up a worldwide joint venture company named Accu-Strides, to develop generic products. The company entered into an agreement with Invent Pharma, Spain for the development and supply of injectible products to a joint venture company for marketing in Spain and Portugal. Also, they agreed to enter into a joint venture agreement with Turkey's leading pharmaceutical company Abdi Ibrahim Pharmaceuticals to be named Abdi-Strides, to introduce a range of specialty pharmaceutical products developed by Strides for Turkey and neighboring markets. In the year 2007, the company acquired 99.59% stake in Grandix Pharmaceuticals Ltd, a branded pharmaceutical company in India. The company through Arcolab International Ltd, UK incorporated Strides Arcolab Hong Kong Ltd, Hong Kong, Strides Arcolab Malaysia SDN BHD, Malaysia and Strides Arcolab Sdn Bhd, Brunei in Asia. Strides Italia s.r.l. was incorporated as a wholly owned subsidiary of Strides Arcolab International Ltd, UK for acquiring the USFDA approved fermentation facility of Diaspa s.p.a., Italy. The company also acquired 74% stake in Strides Vital Nigeria Ltd, Nigeria, through their wholly owned subsidiary Strides Africa Ltd. Sequent Scientific Ltd ceased to be a subsidiary of the company consequent to the sale of entire shareholding. As part of the international restructuring of operations, the company set up Starsmore Ltd, wholly owned subsidiary of the company and Linkace Ltd, the wholly owned subsidiary of Starsmore Ltd in Cyprus. As part of the broad and strategic partnership entered into with the Aspen Group of South Africa, Co-Pharma Ltd, UK, Formule Naturelle (Proprietary) Ltd, South Africa became the subsidiaries of the company. Also, Onco Therapies Ltd, a company incorporated for oncolytics business in India became a subsidiary of the company. In the year 2008, the company completed a series of divestments and acquisitions and rearranged their business on 3 specific business segments, namely Manufacturing and Research and Development, International Front-ended Business-Generics and Brands and Nutraceuticals Business. As part of their continuous effort to concentrate and strengthen the core business the company divested their stake in Strides Italia S.r.l. In March 2008, consequent to Aspen Group acquiring 50% shareholding in Lakerose Ltd, Strides Latina SA, Uruguay, Cellofarm Ltda., Brazil, Solara SA De CV, Mexico and Casa de Representaciones Sumifarma CA, Venezuela ceased to be subsidiaries of the company. Quantum Remedies Pvt Ltd (QRPL), a company incorporated by Quantum Life Sciences Pvt Ltd, became a wholly owned subsidiary of the company. QRPL acquired assets of a 100% EOU at Palghar, Maharashtra to cater to the African Market. Strides CIS Ltd, Cyprus became a subsidiary of the company through Linkace Ltd, Cyprus. This company was formed for operating in the Ukrainian market. The company through Linkace Ltd acquired 55.46% stake in Ascent Pharmahealth Ltd, an ASX listed company. Consequent to the acquisition of Ascent Pharmahealth Ltd, Genepharm Australia Ltd, New Zealand, Genepharm Pty Ltd, Australia became subsidiaries of the company. In the second quarter ended June 2009, Strides Technology & Research Pvt Ltd became a wholly owned subsidiary of the company. Also, the company renamed one of their wholly owned subsidiaries Quantum Life science Pvt Ltd as Strides Specialties Pvt Ltd. In April 2009, the company announced a major corporate reorganization of their business involving splitting of their operations into three separate entities, namely Specialty Pharmaceuticals, Pharmaceuticals & R&D. The shareholders approved to sell the undertaking comprising Specialty Pharmaceuticals Business and Research and Development Business on a going concern basis, to Strides Specialties Pvt Ltd and Strides Technology and Research Pvt Ltd respectively with effect from July 01, 2009. The Pharmaceuticals Business to continue under Strides Arcolab Ltd. In May 2009, the company commenced commercial supplies of Oseltamivir capsules for Influenza-A (HIN1) virus also known as Swine Flu to various countries. On 8 March 2008, the Company allotted 4,000,000 equity shares of Rs. 10/- each at a premium of Rs. 390 per equity share to M/s. Dobliss Holdings Limited (3,111,440 shares) and Blissup Holdings Limited (888,560 shares) against conversion of fully convertible debentures. On 17 June 2008, the Company allotted 1,045,725 equity shares of Rs. 10/- each at a premium of Rs.390 per equity share to M/s. Blissup Holdings Limited against conversion of fully convertible debentures. During FY2008, Onco Therapies Limited (OTL), the joint venture between the Company and Aspen Group concluded an outlicensing and supply agreement with leading multinational pharmaceutical corporation, GIaxoSmithKline, UK (GSK). In terms of the agreement, OTL will license intellectual property and supply finished dosage form pharmaceuticals to GSK. The licensing and supply agreement is for 95 emerging market countries excluding Sub-Saharan Africa and India. In FY 2008, the Company acquired controlling stake (55.46%) in Ascent Pharmahealth Limited. The shares were acquired against vending of Company's Australian and Asian (other than India) business in exchange for the shares in Ascent Pharmahealth Limited. In FY 2008, the Company made additional investment of Rs.117.89 Million in the share capital of Onco Therapies Limited, a subsidiary of the Company. This investment was made by way of transfer of assets pertaining to Oncology plant, which is under construction. In addition, it made additional investment of Rs. 2.36 Million in the share capital of Grandix Pharmaceuticals Limited, Chennai, taking the total stake to 99.98%. In a transaction that was closed on 24 January 2012, the Company sold its Australia and South East Asian Business to Watson Pharmaceuticals Inc., USA for AUD 375 Million resulting in divestment of stake in Ascent Pharmahealth Limited, Australia and its subsidiaries. In February 2012, the Brazilian Sterile Penems facility received US FDA approval. This state-of-the-art facility manufactures sterile dry powder injectables of Penems. The company redeemed the outstanding USD 80 Million Foreign Currency Convertible Bonds (FCCBs) on 27 June 2012. The Company had originally raised USD 100 Million FCCBs in the year 2007 and bought back USD 20 Million during the year 2009. In FY 2012, the Company entered into an in-licensing agreement to collaborate with Gilead Sciences, Inc. to promote access to high-quality, low-cost generic versions of Gilead's HIV medicine emtricitabine (FTC) in developing countries - including fixed-dose combinations of emtricitabine co-formulated with other Gilead HIV medicines. During FY 2012, the French Development Financing Institution Proparco invested USD12.5 Million in the form of equity participation for a 20% stake in Strides' African front-end arm, valuing the African operations at about USD 60 Million. During the year 2012, the Company consolidated its stake in Inbiopro Solutions Private Limited, from the initial holding of 70% to 96.79%. In addition, it further consolidated its stake to 100% and consequently Inbiopro became a wholly owned subsidiary of the Company. In FY 2012, the Company through its wholly owned subsidiary, Agila Specialties Private Limited acquired a USFDA approved Sterile Formulations facility situated at Hosur, Tamil Nadu from Star Drugs and Research Labs Limited.During the year 2012, the Company through wholly owned subsidiary Agila Specialties Pharma Corporation, Canada, formed a joint venture with Jamp Pharma, a Canadian generic drug company, to introduce a variety of quality injectable generic drugs in Canada. In December 2012, the Company with its subsidiary Agila Specialties Private Limited collaborated with Eli Lilly to expand delivery of cancer medicines in the emerging markets. As a part of this arrangement, Lilly will in-license a portfolio of high quality, branded generic injectable and oral cancer medicines from Agila Specialties, the specialties division of Strides. In March 2013, the Company's wholly owned subsidiary, Agila Biotech (Malaysia) Sdn. Bhd, Malaysia, entered into an arrangement with Bio-XCell Sdn Bhd for the establishment of customised biotech facility located in the Bio-XCell ecosystem in Johor, Malaysia. In May 2015, the Company announced that Strides Pharma Global Pte. Ltd, Singapore and Strides (Australia) Pharma Pty Ltd, Australia, both wholly owned subsidiaries of the Company signed definitive agreements with certain wholly owned subsidiaries of Aspen Pharmacare Holdings Limited, to acquire a generic pharmaceutical business in Australia together with certain branded pharmaceutical assets. During FY 2015, Fagris Medica Private Limited, India and Altima Innovation Inc, USA became subsidiaries of the Company; Stelis Biopharma Private Limited, India merged with Inbiopro Solutions Private Limited, India; and Plus Farma ehf, Iceland, Strides Australia Pty Ltd, Australia and Strides S.A Pharmaceuticals Pty Ltd., South Africa were wound up. In FY 2016, Shasun Pharmaceuticals Limited successfully completed the merger with Strides Pharma (Company) forming the new identity Strides Shasun Limited effective from 19 November 2015. The merger provided synergies of complementary product portfolio, strong R&D infrastructure and de-risked manufacturing base. The company had entered into an agreement with GMS Holdings, ('GMS'), whereby GMS or its affiliates would invest USD 21.90 Million for 25.10% stake in Stelis Biopharma Private Limited, India, to fund its Greenfield project. Pursuant to the approval, 69,813 equity shares of Stelis Biopharma Private Limited were issued to GMS Pharma (Singapore) Pte. Ltd. Post this allotment, Strides holding in Stelis is 74.90%. During FY16, the Company acquired erstwhile Ranbaxy's Solus' and Solus Care' divisions operating in the Central Nervous System (CNS) segment in India from Sun Pharmaceuticals Limited. The arrangement involved transfer of these two marketing divisions, along with their employees to the Company for a consideration of Rs.16,500 Lakhs. In February 2016, Strides Pharma Global Pte. Ltd, Singapore acquired a strategic stake in Generic Partners Holdings Co. Pty Ltd., and its subsidiaries, which includes an Australian pharmaceutical supply and research company. The acquisition provided the Company immediate access to 47 commercialized marketing authorizations, with a portfolio of over 180 molecules, 22 registrations pending approval with TGA and strong pipeline of 32 molecules including host of drugs. In FY 2016, the Group (Strides Pharma) acquired a controlling stake in Universal Corporation Limited, Kenya, a Nairobi-based pharmaceutical manufacturing and marketing company which is strongly entrenched in the East African territory with its front-end business and has supply contracts with key donor agencies. The acquisition also provides access to one of the two WHO prequalified manufacturing plant sites in Africa. During FY 2016, the Company's wholly owned subsidiary Strides Pharma Inc., USA acquired an OTC portfolio comprising of Jointflex, Fergon and Vanquish brands/trademarks from Moberg Pharma, Sweden and its affiliates along with applicable production and commercial knowhow, domain name and inventory for an aggregate consideration of USD 10.40 million. The Board of Directors at their meeting held on 16 May 2016 approved the divestment of Shasun Pharma Solutions Ltd, UK (SPSL). Divestment would be for an enterprise value not less than GBP 25 million with an equity value of GBP 6 million, to be discharged by cash and on such terms and conditions decided by the Board. During the year 2016, pursuant to completion of merger of Shasun Pharmaceuticals with the Company on November 20, 2015 the Company allotted 21,017,329 equity shares of Rs 10/- each to shareholders of erstwhile Shasun Pharmaceuticals. Shareholders of the Company had approved raising of long-term funds by way of issuance of GDR's/ ADR's/ FCCBs / QIP or such other equity linked instruments as may be permissible for an amount up to Rs 1,50,000 Lakhs including a green shoe option. In accordance with the said approval, the Company had completed the placement of equity shares through QIP. On December 23, 2015, the Company has allotted 8,628,028 equity shares of Rs 10/- each at a price of Rs 1,278/- per share (including a premium of Rs 1,268/- per share). During FY 2018, Arrow Pharmaceuticals, a step-down subsidiary of the Company in Australia, acquired 100% stake in Amneal Pharmaceuticals, Australia. The acquisition has enabled improve Arrow's generics market share thereby expanding its first-line pharmacies to 1200 stores and provided significant synergy opportunities with 100 molecules being common with Arrow Portfolio. Strides Pharma Asia, the Company's wholly owned subsidiary in Singapore, acquired controlling stake in Trinity Pharma, a company incorporated in South Africa. The transaction enabled Strides to establish a presence in high entry market of South Africa where product dossier approval takes more than 5 years; enabling access to pipeline of more than 110 product dossiers and facilitating ARV launch in private non-tender market in South Africa.During the year 2018, Amneal Pharmaceuticals, Australia, a step-down subsidiary of the Company, entered into a Joint Venture arrangement with Douglas Pharmaceuticals Australia Pty Limited, Australia. Amneal holds approx. 50% stake in the JV Company viz., MyPak Solutions Australia Pty Ltd, Australia. During FY18, the Company exited from the India Brand Business. India Brand Business comprising of a portfolio of 130 brands in the domains of Neurology, Psychiatry, Nutraceuticals, Gastro etc., along with the employees forming part of the said business was sold to Eris Lifesciences Limited, India for a consideration of Rs.410 Crore. It also divested stake in Strides Healthcare Private Limited, a subsidiary company that was catering to the Brands Business to Eris for a consideration of Rs.90 Crore.During the year 2018, through a composite Scheme of Arrangement between the Company, SeQuent Scientific Limited and Solara Active Pharma Sciences Limited and their respective shareholders and creditors under section 230-232 of the Companies Act, 2013, the Company completed the demerger of its Commodity API Business to Solara. Pursuant to the aforesaid Scheme, the Human API business of SeQuent was also demerged to Solara. Appointed Date and Effective Date for demerger was 1 October 2017 and 31 March 2018, respectively. The Scheme received nod of the Equity Shareholders of the Company on 27 December 2017 and approval of the National Company Law Tribunal, Mumbai Bench vide its Order dated 9 March 2018. Consequent to the above, Solara allotted shares to the Equity Shareholders of the Company as at the Record Date, 9 April 2018, as consideration under the Composite Scheme on 11 April 2018. As provided in the Composite Scheme, Solara was listed on Bombay Stock Exchange (BSE) and National Stock Exchanges (NSE) respectively on 27 June 2018. As at March 31, 2018, the company had 51 subsidiaries (46 overseas and 5 in India), 3 Joint Ventures (2 overseas and 1 in India) and 4 associate companies (3 overseas and 1 in India). On 20 April 2018, the Company entered into Business Purchase Agreement with Solara Active Pharma Sciences Limited, India to sell the assets consisting of Plant & machinery, equipment, computer software and other related capital work in progress and business conducted by the Company at Strides API Research Centre (SRC) along with the employees for a consideration of Rs.357.28 Million and working capital subject to adjustment and finalization for Rs.8.26 Million. As on 31 March 2019,the company has 5 Indian subsidiaries,48 overseas subsidiaries,2 overseas joint venture companies,2 Indian associate companies and 4 overseas associate companies. During the year 2018-19, R&D operations of the Company remained on track with 21 ANDAs filings as against the planned range of 20-25 ANDA filings in the year. Your Company also received 15 product approvals in FY 2019 including PARA IV approvals for Cinacalcet and Milnacipran Hydrochloride. In July 2019, Strides Pharma Global Pte. Limited (SPG), a step down subsidiary of the Company in Singapore, entered into a joint venture arrangement with Sun Moral International (HK) Limited, Hong Kong (Sun Moral) to fast track its entry into China, the second largest pharmaceuticals market in the world. In August 2019, Strides Pharma Inc (SPI), a step-down subsidiary of the Company in the US, acquired a US FDA approved soft gel manufacturing facility in Florida, USA from Micelle BioPharma Inc. The facility is one of the very few manufacturing facilities in the US with a soft-gel capsule manufacturing suite for formulations with containment needs. In September 2019, Strides Pharma Global Pte. Limited (SPG), a step-down subsidiary of the Company in Singapore acquired 70% equity stake in Fairmed Healthcare AG (Fairmed), a Switzerland based generic pharma company. In January 2020, Board of Directors of the Company approved the Scheme of Amalgamation for merger of its wholly owned subsidiary, Vivimed Life Sciences Private Limited (Vivimed) into the Company. Appointed Date for the said amalgamation is October 1, 2020 or such other date as the National Company Law Tribunal (NCLT) or such other competent authority may direct in relation to the amalgamation of Vivimed with Strides. During the previous year, the Board of Directors had proposed to divest the Group's equity interest in the Australia business to Dennis Bastas- Executive Chairman of Arrow Pharmaceuticals Pty Limited, Australia (Arrow). Further, the group had obtained the approval from the Company's shareholders' in the EGM held on March 27, 2019. On July 10, 2019, the Group completed the divestment of its Australia business for a consideration of AUD 406 Million (including a deferred consideration of AUD 106 Million) reduced by the bank debt settlement of AUD 22.47 Million. Additionally, the Group has retained global access to IP's of over 140 products and has concurrently entered into a preferred supply agreement with Arrowtex. The Board of Directors of the Company on July 29, 2019 have approved the Scheme of Amalgamation ('the Scheme') u/s 230 to 232 of the Companies Act, 2013, between Strides Pharma Science Limited, Strides Emerging Market Limited, Arrow Remedies Private Limited, and Fagris Medica Private Limited with an appointed date of Apr 1, 2019. The Scheme has been filed with National Company Law Tribunal(NCLT) for approval. The NCLT convened shareholders meeting on February 20, 2020 and the merger has been approved by the shareholders. The Scheme is currently pending with the NCLT for their approval. The NCLT convened shareholders meeting on February 20, 2020 and the merger has been approved by the shareholders. The NCLT, Bangalore Bench has approved the Scheme vide order dated May 28, 2020 and the scheme is now pending for approval with the Mumbai Bench of NCLT. As on 31 March 2020, the Company has 5 Indian subsidiaries, 36 overseas subsidiaries, 1 overseas joint venture companies, 2 Indian associate companies and 10 overseas associate companies. During the quarter ended June 30, 2020, the Group gained controlling interest in Fairmed Healthcare AG, Switzerland, thereby making it a Subsidiary of the Group. During the year 2021, Company's direct/step-down wholly owned subsidiaries viz., Arrow Remedies Private Limited, Fagris Medica Private Limited and Strides Emerging Markets Limited (SEML) (collectively Transferor Companies) amalgamated into the Company pursuant to a Scheme of Amalgamation, which received approval of the Hon'ble National Company Law Tribunal (NCLT) Bench of Bengaluru (for SEML) on May 28, 2020 and NCLT Mumbai (for the Company, Arrow and Fagris) on November 06, 2020. Appointed Date for the said Amalgamation was April 01, 2019. In February 2021, the Board of Directors of the Company demerged its biopharma business into Stelis, which was listed as a separate entity through a Scheme of Arrangement. During year 2021, Company invested USD 40 Million into Stelis. In March 2021, Stelis completed a USD 155 Million Series B and Series C fund raise from existing and marquee long term investors as primary investment. In FY 2021-22, Company acquired a Chestnut Ridge manufacturing facility, a step-down Wholly Owned Subsidiary of the Company in the US with ~150 ANDAs in diversified dosage formats, which includes Controlled Substances, Hormones, Nasal Sprays to accelerate portfolio differentiation. ANDA Portfolios was acquired by Strides Pharma Global Pte. Limited, a step-down wholly owned subsidiary of the Company in Singapore. The wholly owned subsidiary, Vivimed Life Sciences Private Limited was merged with the Company through a Scheme of Amalgamation in February, 2022 and the merger was given effect on April 1, 2022. In 2023, Company acquired Endo facility, enabling to manufacture nasal sprays and control substances. To develop nasal sprays, it partnered with Orbicular, a technology based company, to leverage their expertise in this area. The Company announced creation of OneSource', an independent Specialty Pharma Contract Development and Manufacturing Organisation (CDMO) in 2023-24. Arco Lab acquired 25% stake in Neviton during August, 2022 and further acquired additional 25% stake in Neviton, thereby consolidating its stake to 50% and Neviton became a Subsidiary of Arco Lab and consequently of the Company effective on January 5, 2024.

Parent Organisation

Indian Private

NSE Symbol

STAR

Founded

1990

View more stocks

WANBURY LIMITED

₹313.1

12.8%

SAT KARTAR SHOPPING LTD

₹171.75

8.56%

THEMIS MEDICARE LTD.

₹146.83

6.65%

IND-SWIFT LIMITED

₹15.0

5.63%

JFL LIFE SCIENCES LIMITED

₹21.45

4.88%

SUN PHARMA ADV.RES.CO.LTD

₹158.83

4.78%

VENUS REMEDIES LIMITED

₹340.0

4.46%

VAISHALI PHARMA LIMITED

₹12.81

4.4%

MONO PHARMACARE LIMITED

₹25.0

4.16%

JUBILANT PHARMOVA LTD

₹941.4

3.95%

Popular stocks

Rail Vikas Nigam
Suzlon Energy
NHPC
Yes Bank
TATA Motors
BHEL
HDFC Bank
State Bank of India
TATA Power
TATA Steel
NBCC India
Infosys India
Adani Power
IFCI
Coal India
OLA Electric

What’s trending

Top gainers Top losers 52-week high 52-week low All stocks

All stocks

INNOMET

INNOMET ADVANCED MATERI L

198.6

+33.1 +20%

ZEELEARN

ZEE LEARN LIMITED

7.87

+1.31 +19.97%

YOGISUNG

YOGI SUNG-WON (INDIA) LTD.

12.32

+2.05 +19.96%

ZEELEARN

ZEE LEARN LTD.

7.83

+1.3 +19.91%

View all

Top gainers

BEL

BHARAT ELECTRONICS LTD

362.45

+12.05 +3.44%

TATAMOTORS

TATA MOTORS LIMITED

740.4

+12.30 +1.69%

EICHERMOT

EICHER MOTORS LTD

5554

+88.00 +1.61%

NTPC

NTPC LTD

346.15

+4.20 +1.23%

View all

Top losers

INDUSINDBK

INDUSIND BANK LIMITED

755.7

-24.80 -3.18%

BHARTIARTL

BHARTI AIRTEL LIMITED

1817.4

-49.80 -2.67%

HCLTECH

HCL TECHNOLOGIES LTD

1670.3

-25.70 -1.52%

SBIN

STATE BANK OF INDIA

796.8

-10.95 -1.36%

View all

Frequently asked questions

What is share price of STRIDES PHARMA SCI LTD?
<p> As of May 16 2025 01:51 PM, at May 16 2025 01:51 PM, the STRIDES PHARMA SCI LTD share price stands at Rs.660.65.</p>
What is the market cap of STRIDES PHARMA SCI LTD?
<p>As of May 16 2025 01:51 PM, the market cap of STRIDES PHARMA SCI LTD stands at Rs.6071.35 Cr. <br /> </p>
What is the PE and PB ratio of STRIDES PHARMA SCI LTD?
<p> The PE and PB ratios of STRIDES PHARMA SCI LTD is 69.49 ratio and 381.62 ratio as of May 16 2025 01:51 PM.</p>
What is the 52 week high and low of STRIDES PHARMA SCI LTD?
<p>The 52 week high and low of STRIDES PHARMA SCI LTD is Rs.1675.0 and Rs.513.05 as of May 16 2025 01:51 PM.<br /> </p>
How can I buy STRIDES PHARMA SCI LTD share?
<p>You can easily buy&nbsp;STRIDES PHARMA SCI LTD shares on&nbsp;the <b>Bajaj Broking</b> platform by opening a Demat account&nbsp;and verifying your KYC documents online. There are no account opening charges for a Demat account with Bajaj Broking.<br> </p>
Show More Text Show Less Text

Related articles

Article 1

How to Buy Shares

Jan 30, 2025

Read More

share-market-timings-in-india 2

Share Market Timings in India

May 15, 2023

Read More

what-is-trading 3

What is Trading

Mar 25, 2025

Read More

what-is-demat-account 4

What is Demat Account: Meaning, Types & Benefits

May 25, 2021

Read More


Related videos

Features and benefits of Demat Account
 
 

Features and benefits of Demat Account

How to open a Demat and Trading account with us
 
 

How to open a Demat and Trading account with us

Stock market basics for beginners
 
 

Stock market basics for beginners

Features and Benefits of a Trading account
 
 

Features and Benefits of a Trading account

Different types of Demat accounts
 
 

Different types of Demat accounts


Related tags

Top gainers
Top losers
52 week high
52 week low
All stocks

You are here

  1. Home
  2. Investments
  3. Strides Pharma Sci Ltd Share Price

Related links

  • Investments
  • Brokerage calculator
  • Demat account
  • Trading account

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."
 

**Disclaimer: For Bajaj Financial Securities Limited

Investments in securities market are subject to market risk, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit. All leveraged intraday positions will be squared off the same day. There is no restriction on withdrawal of unutilised margin amount. Trade Recommendations are research-calls provided under the SEBI Research Analyst guidelines. Visit https://www.bajajbroking.in/disclaimer for complete disclaimer.

Securities market Products/services are made available only at the discretion of BFSL and subject to the individual contractual terms and conditions of the respective Securities market products/services. You shall be the sole owner of any decision to invest in any BFSL's Securities market products/services.

Securities market products/services may be withdrawn or amended at any time by BFSL without notice and your recourse in such case would be directly to reach out BFSL at connect@bajajfinserv.in or 1800 833 8888.


Powered by Bajaj Financial Securities Limited (Bajaj Broking)

Go To Top

Application Forms

  • Personal Loan
  • Business Loan
  • Home Loan
  • Gold Loan
  • Insta EMI Card
  • Wallet Care
  • Health Insurance
  • Loan for Doctors
  • Fixed Deposit
  • Loan Against Property
  • Loan for Chartered Accountants
  • Open Demat Account
  • Two-wheeler Loan
  • New Car Finance
  • Used Car Loan
  • Loan Against Car
  • Car Loan Balance Transfer and Top-up
  • Mutual Fund
  • Secured Business Loan
  • Loan for Lawyer

Products Portfolio

Loans

  • Personal Loan
  • Insta Personal Loan
  • Business Loan
  • Home Loan
  • Gold Loan
  • MSME Loan
  • Mortgage Loan
  • Loan Against Property
  • Two & Three Wheeler Loan
  • Education Loan on Property
  • Personal Loan for Self-employed Individuals
  • Two-wheeler Loan
  • New Car Finance
  • Used Car Loan
  • Loan Against Car
  • Car Loan Balance Transfer and Top-up
  • Used Cars and Loan

Insurance

  • Health Insurance
  • Car Insurance
  • Pocket Insurance
  • Investment Plans
  • Appliances Extended Warranty
  • Pocket Subscription

Finance for Professionals

  • Loan for Doctors
  • Loan for Chartered Accountants

Investments

  • Fixed Deposit
  • Open Demat Account
  • Mutual Funds
  • NFO (New Fund Offer)
  • ELSS Mutual Funds
  • Equity Mutual Funds
  • Hybrid Mutual Funds
  • Debt Mutual Funds
  • Multi Cap Mutual Funds
  • Large Cap Mutual Funds
  • Mid Cap Mutual Funds
  • Small Cap Mutual Funds
  • Liquid Mutual Funds
  • Aggressive Hybrid Mutual Funds

Pocket Subscription

  • Mobile Protection Plan
  • Wallet Care
  • Fonesafe Lite
  • Neuro Care Plan
  • Health Prime Max
  • Cpp Road Assist
  • Healthy Body Package

Bajaj Mall

  • Smartphones
  • Mattress
  • Smartwatches
  • Cycles
  • Music & Audio
  • Speakers
  • Water Purifiers
  • Laptops
  • Two-wheeler
  • Washing Machine
  • Televisions
  • Air Conditioner
  • Refrigerators
  • Furniture

Services

  • Sign-in to our Customer Portal (My Account)
  • Manage your Profile
  • Manage your Mandate
  • Manage your Loans
  • Manage your Flexi Loans
  • Manage your Insta EMI card
  • Manage your Fixed Deposit

Wallets & Cards

  • Wallet
  • Bajaj Finserv Insta EMI Card

Value Added Services

  • Credit Pass
  • Gold Rate

Payments

  • All Payments
  • Wallet
  • UPI
  • Mobile recharge
  • Electricity Bill Payment
  • DTH Recharge
  • Loan Repayment
  • Gas Booking
  • Rewards
  • Bajaj Pay FASTAg
  • Bajaj Pay Wallet KYC Upgrade
  • Bajaj Pay FASTAg Registration
  • Bajaj Pay FASTag Replacement
  • Bajaj Pay FASTag Closure
Pre-approved Offers
Offers & Promotions
Article and Insights

Calculators

  • Personal Loan EMI Calculator
  • Home Loan EMI Calculator
  • Home Loan Eligibility Calculator
  • Business Loan EMI Calculator
  • Personal Loan Eligibility Calculator
  • Loan Against Property EMI Calculator
  • Education Loan on Property Calculator
  • FD Calculator
  • Gratuity Calculator
  • Income Tax Calculator
  • Top-up Loan Calculator
  • Part-prepayment Calculator
  • GST Calculator
  • Gold Loan Calculator
  • EMI Calculator
  • Used Car Loan EMI Calculator
  • Interest Calculator
  • SIP Calculator
  • Credit Score Simulator
  • Flexi Day Wise Interest Calculator
  • Flexi Transaction Calculator
  • Secured Business Loan EMI Calculator
  • Secured Business Loan Eligibility Calculator
  • Lumpsum Calculator
  • Step Up SIP Calculator
  • BMI Calculator
  • IDV Calculator
  • Commercial Loan EMI Calculator
  • Medical Equipment Finance EMI Calculator
  • Term Loan Calculator
  • Equipment Machinery Loan EMI Calculator
  • Doctor Loan EMI Calculator
  • Doctor Loan Eligibility Calculator
  • Chartered Accountant Loan EMI Calculator
  • Simple Interest Calculator
  • Compound Interest Calculator
  • Brokerage Calculator
  • Mutual Fund Calculator
  • Two wheeler Loan EMI Calculator
  • New Car Loan EMI Calculator

Legal

  • Moratorium Policy (Covid-19)
  • Moratorium Policy March 2020
  • Information Security Practices
  • Information Security Measures
  • Citizens Charter
  • Privacy Policy
  • Phishing
  • Disclaimer
  • Forms Centre
  • Fees & Charges
  • Fair Practices Code
  • Interest Rate Policy
  • Disclosures
  • Cautionary Notice
  • Whistle Blower Policy
  • Confidential Feedback
  • Resolution Plan 2.0
  • Terms & Conditions
  • Resolution Plan 2.0 FAQs
  • Ombudsman Scheme
  • SMA/NPA Account Classification
  • Terms of Use
  • Sachet
  • Handover of Property Documents
  • Notices
  • Policy on Fees & Charges
  • BFL - Floating Reference Rates

Reach Us

  • Contact us
  • Raise A Request
  • Frequently Asked Questions
  • Make Online Payment
  • Branch Locator
  • Our Partners
  • Galaxy - Partner portal
  • Bajaj Finserv for Business
  • Call Us

Corporate Office

6th Floor Bajaj Finserv Corporate Office, Off Pune-Ahmednagar Road, Viman Nagar, Pune - 411014

Bajaj Finance Limited Regd. Office

Akurdi, Pune - 411035
Ph No.: 020 7157-6403
Email ID: investor.service@bajajfinserv.in

Corporate Identity Number (CIN)

L65910MH1987PLC042961

IRDAI Corporate Agency (Composite) Regn No.

CA0101
(Valid till 31-Mar-2028)

URN - WEB/BFL/23-24/1/V1

Bajaj Finserv Limited Regd. Office

Bajaj Auto Limited Complex Mumbai - Pune Road,
Pune - 411035 MH (IN)
Ph No.: 020 7157-6064
Email ID: investors@bajajfinserv.in

Corporate Identity Number (CIN)

L65923PN2007PLC130075

Our Companies

  • Bajaj Finserv Ltd.
  • Bajaj Finance Ltd.
  • Bajaj Allianz General Insurance
  • Bajaj Allianz Life Insurance
  • Bajaj Markets
  • Bajaj Housing Finance Ltd.
  • Bajaj Broking
  • Bajaj Finserv Health Ltd.
  • Bajaj Finserv Asset Management Ltd.
Company Name
Download App

© Bajaj Finserv 2007-2025. All rights reserved.